FDA Proposes Ban on Hair Relaxers Containing Formaldehyde
The U.S. Food and Drug Administration (FDA) is taking a significant step towards the potential prohibition of formaldehyde and formaldehyde-releasing chemicals in hair smoothing and hair straightening products. This proposed ban aligns with regulations already in place in the European Union and Canada.

Formaldehyde, which is currently regulated and limited to 0.01% in Canada for use in hair straightening products, has raised concerns due to the inhalation of formaldehyde vapors when these products are heated, such as by a hairdryer or flat iron. This vapor exposure is believed to contribute to respiratory problems and an increased risk of specific cancers.
"The use of hair smoothing products containing formaldehyde and formaldehyde-releasing chemicals is associated with short-term adverse health effects, including sensitization reactions and respiratory issues, as well as long-term health risks, such as an elevated likelihood of certain cancers," stated the FDA in its proposed rule.
Research conducted by the U.S. National Institute of Health (NIH) last year revealed a potential link between the use of hair straightening products and a heightened risk of uterine cancer, with a potentially greater impact on Black women due to their higher usage of such products.
It is essential to note that this proposed ban represents the initial phase of the regulatory process. The FDA is now accepting public comments on the proposal. Following a comprehensive review of these comments, the agency will determine whether further action is necessary.
The FDA currently advises against the use of hair-straightening products that contain formaldehyde and similar substances. Formaldehyde gas inhalation can result in a range of adverse effects, from immediate symptoms such as eye and throat irritation, coughing, wheezing, and chest pain, to more chronic issues like frequent headaches, asthma, skin irritation, allergic reactions, and potentially cancer, as stated in a fact sheet available on the agency's website.
2026-07-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
The role of lauryl-dimethyl-amine-oxide for hair in shampoo
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
Hair Care Products & Heat Styling May Change Indoor Air Composition & Increase VOCs
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
Provital's Marine-derived Densinaria Boosts Hair Volume & Strength
-
MANE Unveils FRESHPLEX™: A Multifaceted Hair Experience Defying Discomfort
-
Anticipating the Beauty Boom: Peptides Take Center Stage in 2024, Predicts NQ Innovations
Recommend Reading
-
This week, the domestic anhydrous hydrogen fluoride market maintained a high-level consolidation operation (3.16-3.19)
-
Formic Acid Shows Moving Average Crossover, Upward Momentum Limited
-
This Week's Caustic Soda Prices Remain Firm (3.16-3.20)
-
Methanol Market Prices Fluctuate Narrowly
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
China's Urea Market Shows Weak Performance (3.13-3.19)
-
Cytosine: Structure, DNA Pairing, and Role in Genetics
-
Bovine Serum Albumin (BSA): Role in Cell Culture & Laboratory Applications
-
This Week's Styrene Market Fluctuates and Rises (3.16-3.20)
-
Sodium Metabisulfite Prices Rise This Week (Mar. 16-20)